3M intends to spin off its health care business, resulting in two public companies.
The new 3M business will serve the industrial and consumer end markets through global material science innovation, while the health care company will be a global diversified healthcare technology company focused on wound care, healthcare IT, oral care, and biopharma filtration.
The company, which will have separate boards and management teams, expects the split to enhance agility and focus, and will enable to tailor capital allocation strategies and make company-specific investment decisions.
"Today's actions advance our ability to create value for customers and shareholders," said Mike Roman, 3M chairman and CEO, in a statement. "Disciplined portfolio management is a hallmark of our growth strategy. Our management team and board continually evaluate the strategic options that will best drive long term sustainable growth and value. The decision to spin off our Health Care business will result in two well-capitalized, world-class companies, well positioned to pursue their respective priorities."
3M’s consumer business has it sitting as No. 16 on the 2021 CGT Top 100 Consumer Goods Ranking. This new business recorded $26.8 billion in sales in 2021, and will continue to leverage its innovation to capitalize on customer opportunities aligned with such key global megatrends as electronics, safety, mobility, digitization, home improvement, and sustainability, according to the company.
It will also continue to prioritize strategic opportunities that include investments in growth, productivity, and sustainability while maintaining a proactive approach to portfolio management, it noted.
The transaction is expected to complete by the end of 2023.